Free Trial

Mizuho Initiates Coverage on Select Medical (NYSE:SEM)

Select Medical logo with Medical background

Stock analysts at Mizuho initiated coverage on shares of Select Medical (NYSE:SEM - Get Free Report) in a report released on Wednesday, MarketBeat.com reports. The firm set an "outperform" rating and a $25.00 price target on the health services provider's stock. Mizuho's price target would suggest a potential upside of 64.58% from the stock's previous close.

SEM has been the subject of a number of other research reports. Royal Bank of Canada dropped their target price on shares of Select Medical from $47.00 to $23.00 and set an "outperform" rating for the company in a report on Monday, February 24th. StockNews.com upgraded shares of Select Medical from a "hold" rating to a "buy" rating in a research report on Friday, February 21st. Benchmark upgraded shares of Select Medical from a "hold" rating to a "buy" rating and set a $23.00 price target for the company in a report on Monday, February 24th. Finally, UBS Group reduced their price objective on Select Medical from $40.00 to $21.00 and set a "neutral" rating on the stock in a research report on Friday, January 3rd. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $26.80.

Check Out Our Latest Stock Report on Select Medical

Select Medical Stock Performance

Shares of Select Medical stock traded down $1.17 during trading on Wednesday, hitting $15.19. 230,880 shares of the stock were exchanged, compared to its average volume of 814,307. Select Medical has a 1-year low of $14.99 and a 1-year high of $40.98. The stock has a market capitalization of $1.96 billion, a price-to-earnings ratio of 9.21, a price-to-earnings-growth ratio of 0.64 and a beta of 1.38. The company has a fifty day moving average price of $17.27 and a 200-day moving average price of $22.83. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37.

Select Medical (NYSE:SEM - Get Free Report) last issued its quarterly earnings data on Thursday, February 20th. The health services provider reported $0.18 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.29 by ($0.11). Select Medical had a return on equity of 14.04% and a net margin of 3.23%. The firm had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.50 billion. As a group, equities analysts predict that Select Medical will post 1.17 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in SEM. Jane Street Group LLC grew its holdings in Select Medical by 14.2% during the third quarter. Jane Street Group LLC now owns 127,504 shares of the health services provider's stock worth $4,446,000 after buying an additional 15,827 shares in the last quarter. Barclays PLC increased its stake in Select Medical by 396.0% in the 3rd quarter. Barclays PLC now owns 192,357 shares of the health services provider's stock valued at $6,707,000 after buying an additional 153,576 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Select Medical by 2.0% in the 3rd quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider's stock worth $85,180,000 after buying an additional 46,880 shares during the last quarter. Virtu Financial LLC bought a new stake in Select Medical during the third quarter worth $210,000. Finally, Wilmington Savings Fund Society FSB purchased a new stake in shares of Select Medical during the 3rd quarter valued at $81,000. 89.48% of the stock is owned by institutional investors and hedge funds.

About Select Medical

(Get Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Featured Stories

Analyst Recommendations for Select Medical (NYSE:SEM)

Should You Invest $1,000 in Select Medical Right Now?

Before you consider Select Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.

While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines